Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury

Frank Porreca, QingBo Tang, Di Bian, Maureen Riedl, Robert Eide, Josephine Lai

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

Previous studies in rats have shown that spinal morphine loses potency and efficacy to suppress an acute nociceptive stimulus applied to the tail or the paw following injury to peripheral nerves by tight ligation of the L5/L6 spinal nerves. Additionally, intrathecal (i.th.) morphine is ineffective in suppressing tactile allodynia at fully antinociceptive doses in these animals. The molecular basis for this loss of morphine potency and efficacy in nerve injury states is not known. One possible explanation for this phenomenon is a generalized, multi-segmental loss of opioid mu (μ) receptors in the dorsal horn of the spinal cord after nerve injury. This hypothesis was tested here by determining whether nerve injury produces (a) a decrease in μ receptors in the lumbar spinal cord; (b) a decrease in the affinity of ligand-receptor interaction, (c) a decrease in the fraction of high-affinity state of the μ receptors and (d) a reduced ability of morphine to activate G-proteins via μ receptors. Lumbar spinal cord tissues were examined 7 days after the nerve injury, a time when stable allodynia was observed. At this point, no differences were observed in the receptor density or affinity of [3H]DAMGO (μ selective agonist) or [3H]CTAP (μ selective antagonist) in the dorsal quadrant of lumbar spinal cord ipsilateral to nerve injury. Additionally, no change in morphine's potency and efficacy in activating G- proteins was observed. In contrast, staining for μ opioid receptors using μ-selective antibodies revealed a discrete loss of μ opioid receptors localized ipsilateral to the nerve injury and specific for sections taken at the L6 level. At these spinal segments, μ opioid receptors were decreased in laminae I and II. The data indicate that the loss of μ opioid receptors are highly localized and may contribute to the loss of morphine activity involving input at these spinal segments (e.g., foot-flick response). On the other hand, the lack of a generalized loss of opioid μ receptors across spinal segments makes it unlikely that this is the primary cause for the loss of potency and efficacy of μ opioids to suppress multi-segmental reflexes, such as the tail-flick response.

Original languageEnglish (US)
Pages (from-to)197-203
Number of pages7
JournalBrain Research
Volume795
Issue number1-2
DOIs
StatePublished - Jun 8 1998

Fingerprint

mu Opioid Receptor
Morphine
Opioid Receptors
Spinal Cord
Wounds and Injuries
Hyperalgesia
GTP-Binding Proteins
Substantia Gelatinosa
Ala(2)-MePhe(4)-Gly(5)-enkephalin
Peripheral Nerve Injuries
Spinal Nerves
Aptitude
Opioid Analgesics
Ligation
Reflex
Tail
Foot
Staining and Labeling
Ligands
Antibodies

Keywords

  • G-protein
  • Morphine
  • Mu opioid receptor
  • Neuropathic pain
  • Rat

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury. / Porreca, Frank; Tang, QingBo; Bian, Di; Riedl, Maureen; Eide, Robert; Lai, Josephine.

In: Brain Research, Vol. 795, No. 1-2, 08.06.1998, p. 197-203.

Research output: Contribution to journalArticle

Porreca, Frank ; Tang, QingBo ; Bian, Di ; Riedl, Maureen ; Eide, Robert ; Lai, Josephine. / Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury. In: Brain Research. 1998 ; Vol. 795, No. 1-2. pp. 197-203.
@article{552de0c2d824443d96b659c5d3f29c06,
title = "Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury",
abstract = "Previous studies in rats have shown that spinal morphine loses potency and efficacy to suppress an acute nociceptive stimulus applied to the tail or the paw following injury to peripheral nerves by tight ligation of the L5/L6 spinal nerves. Additionally, intrathecal (i.th.) morphine is ineffective in suppressing tactile allodynia at fully antinociceptive doses in these animals. The molecular basis for this loss of morphine potency and efficacy in nerve injury states is not known. One possible explanation for this phenomenon is a generalized, multi-segmental loss of opioid mu (μ) receptors in the dorsal horn of the spinal cord after nerve injury. This hypothesis was tested here by determining whether nerve injury produces (a) a decrease in μ receptors in the lumbar spinal cord; (b) a decrease in the affinity of ligand-receptor interaction, (c) a decrease in the fraction of high-affinity state of the μ receptors and (d) a reduced ability of morphine to activate G-proteins via μ receptors. Lumbar spinal cord tissues were examined 7 days after the nerve injury, a time when stable allodynia was observed. At this point, no differences were observed in the receptor density or affinity of [3H]DAMGO (μ selective agonist) or [3H]CTAP (μ selective antagonist) in the dorsal quadrant of lumbar spinal cord ipsilateral to nerve injury. Additionally, no change in morphine's potency and efficacy in activating G- proteins was observed. In contrast, staining for μ opioid receptors using μ-selective antibodies revealed a discrete loss of μ opioid receptors localized ipsilateral to the nerve injury and specific for sections taken at the L6 level. At these spinal segments, μ opioid receptors were decreased in laminae I and II. The data indicate that the loss of μ opioid receptors are highly localized and may contribute to the loss of morphine activity involving input at these spinal segments (e.g., foot-flick response). On the other hand, the lack of a generalized loss of opioid μ receptors across spinal segments makes it unlikely that this is the primary cause for the loss of potency and efficacy of μ opioids to suppress multi-segmental reflexes, such as the tail-flick response.",
keywords = "G-protein, Morphine, Mu opioid receptor, Neuropathic pain, Rat",
author = "Frank Porreca and QingBo Tang and Di Bian and Maureen Riedl and Robert Eide and Josephine Lai",
year = "1998",
month = "6",
day = "8",
doi = "10.1016/S0006-8993(98)00292-3",
language = "English (US)",
volume = "795",
pages = "197--203",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury

AU - Porreca, Frank

AU - Tang, QingBo

AU - Bian, Di

AU - Riedl, Maureen

AU - Eide, Robert

AU - Lai, Josephine

PY - 1998/6/8

Y1 - 1998/6/8

N2 - Previous studies in rats have shown that spinal morphine loses potency and efficacy to suppress an acute nociceptive stimulus applied to the tail or the paw following injury to peripheral nerves by tight ligation of the L5/L6 spinal nerves. Additionally, intrathecal (i.th.) morphine is ineffective in suppressing tactile allodynia at fully antinociceptive doses in these animals. The molecular basis for this loss of morphine potency and efficacy in nerve injury states is not known. One possible explanation for this phenomenon is a generalized, multi-segmental loss of opioid mu (μ) receptors in the dorsal horn of the spinal cord after nerve injury. This hypothesis was tested here by determining whether nerve injury produces (a) a decrease in μ receptors in the lumbar spinal cord; (b) a decrease in the affinity of ligand-receptor interaction, (c) a decrease in the fraction of high-affinity state of the μ receptors and (d) a reduced ability of morphine to activate G-proteins via μ receptors. Lumbar spinal cord tissues were examined 7 days after the nerve injury, a time when stable allodynia was observed. At this point, no differences were observed in the receptor density or affinity of [3H]DAMGO (μ selective agonist) or [3H]CTAP (μ selective antagonist) in the dorsal quadrant of lumbar spinal cord ipsilateral to nerve injury. Additionally, no change in morphine's potency and efficacy in activating G- proteins was observed. In contrast, staining for μ opioid receptors using μ-selective antibodies revealed a discrete loss of μ opioid receptors localized ipsilateral to the nerve injury and specific for sections taken at the L6 level. At these spinal segments, μ opioid receptors were decreased in laminae I and II. The data indicate that the loss of μ opioid receptors are highly localized and may contribute to the loss of morphine activity involving input at these spinal segments (e.g., foot-flick response). On the other hand, the lack of a generalized loss of opioid μ receptors across spinal segments makes it unlikely that this is the primary cause for the loss of potency and efficacy of μ opioids to suppress multi-segmental reflexes, such as the tail-flick response.

AB - Previous studies in rats have shown that spinal morphine loses potency and efficacy to suppress an acute nociceptive stimulus applied to the tail or the paw following injury to peripheral nerves by tight ligation of the L5/L6 spinal nerves. Additionally, intrathecal (i.th.) morphine is ineffective in suppressing tactile allodynia at fully antinociceptive doses in these animals. The molecular basis for this loss of morphine potency and efficacy in nerve injury states is not known. One possible explanation for this phenomenon is a generalized, multi-segmental loss of opioid mu (μ) receptors in the dorsal horn of the spinal cord after nerve injury. This hypothesis was tested here by determining whether nerve injury produces (a) a decrease in μ receptors in the lumbar spinal cord; (b) a decrease in the affinity of ligand-receptor interaction, (c) a decrease in the fraction of high-affinity state of the μ receptors and (d) a reduced ability of morphine to activate G-proteins via μ receptors. Lumbar spinal cord tissues were examined 7 days after the nerve injury, a time when stable allodynia was observed. At this point, no differences were observed in the receptor density or affinity of [3H]DAMGO (μ selective agonist) or [3H]CTAP (μ selective antagonist) in the dorsal quadrant of lumbar spinal cord ipsilateral to nerve injury. Additionally, no change in morphine's potency and efficacy in activating G- proteins was observed. In contrast, staining for μ opioid receptors using μ-selective antibodies revealed a discrete loss of μ opioid receptors localized ipsilateral to the nerve injury and specific for sections taken at the L6 level. At these spinal segments, μ opioid receptors were decreased in laminae I and II. The data indicate that the loss of μ opioid receptors are highly localized and may contribute to the loss of morphine activity involving input at these spinal segments (e.g., foot-flick response). On the other hand, the lack of a generalized loss of opioid μ receptors across spinal segments makes it unlikely that this is the primary cause for the loss of potency and efficacy of μ opioids to suppress multi-segmental reflexes, such as the tail-flick response.

KW - G-protein

KW - Morphine

KW - Mu opioid receptor

KW - Neuropathic pain

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=0032496689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032496689&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(98)00292-3

DO - 10.1016/S0006-8993(98)00292-3

M3 - Article

C2 - 9622629

AN - SCOPUS:0032496689

VL - 795

SP - 197

EP - 203

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -